Allgens Medical Technology Co. Ltd.
SHH: 688613.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Menglong Cui
- Employees
- 271
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- CN¥2.9B
- Website
- https://www.allgensmed.com
Loading 688613…
Loading profile data…Frequently asked questions about 688613
What does Allgens Medical Technology Co. Ltd. (688613.SS) do?
Allgens Medical Technology CO., LTD., a medical device company, develops and manufactures platforms of biomimetic synthetic bone grafts for use in regions of compromised cancellous and cortical bone worldwide. The company offers BonGold mineralized collagen scaffold bone graft; Alligator high performance bone marrow aspirator; and OssaNova miner...
Where does 688613.SS trade?
Allgens Medical Technology Co. Ltd. (688613.SS) trades on the Shanghai Stock Exchange.
What sector is 688613.SS in?
Allgens Medical Technology Co. Ltd. (688613.SS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Allgens Medical Technology Co. Ltd.?
Menglong Cui is the chief executive officer of Allgens Medical Technology Co. Ltd. (688613.SS).
Where is Allgens Medical Technology Co. Ltd. headquartered?
Allgens Medical Technology Co. Ltd. is headquartered in China.
Does 688613.SS pay a dividend?
Yes — Allgens Medical Technology Co. Ltd. (688613.SS) paid a trailing twelve-month dividend of CNY 0.06 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688613.SS go public?
Allgens Medical Technology Co. Ltd. (688613.SS) completed its initial public offering in 2021.